Efficacy of Erector Spinae Plane Block Versus Infraclavicular Subomohyoid Block in Shoulder Surgery
NCT ID: NCT04183244
Last Updated: 2020-12-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1/PHASE2
80 participants
INTERVENTIONAL
2019-08-15
2021-02-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Erector spinae block
Ultrasound guidance will be used to visualize the transverse processes of T2 and the overlying muscles.
Under sterile conditions, a 5-cm, 21-gauge needle will be inserted using the out-of-plane technique parallel to the sagittal plane directly over the transverse process,then 30mL of the local anesthetic solution will be injected and observed for the linear spread of LA the under direct ultrasound visualization
Erector spinae block
A 5-cm needle prick in the back of the patient 3 cm lateral to mid-line under sterile conditions, with ultrasound guidance.
infraclavicular subomohyoid block
Performing posterior approach infraclavicular BP block followed by subomohioid block via the same puncture site under ultrasound guidance.
Infraclavicular subomohyoid (ISO) block
Under complete aseptic precaution, 12 cm needle will be inserted 2cm superior to the clavicle and advanced retroclavicular, with ultrasound guidance.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Erector spinae block
A 5-cm needle prick in the back of the patient 3 cm lateral to mid-line under sterile conditions, with ultrasound guidance.
Infraclavicular subomohyoid (ISO) block
Under complete aseptic precaution, 12 cm needle will be inserted 2cm superior to the clavicle and advanced retroclavicular, with ultrasound guidance.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA physical status I
* Scheduled for shoulder surgery
Exclusion Criteria
* Previous surgery in the same shoulder.
* History of psychiatric disorder.
* Pulmonary disease.
* Contraindication to regional nerve block (e.g. skin infection at the puncture site, coagulopathy).
* Allergy to any of medications that will be used
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Randa Ali Shoukry
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Randa Ali Shoukry
Cairo, Al-Nozha, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Randa A Shoukry, MD
Role: primary
Mona R Hosny, MD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FMASU R 57/2019
Identifier Type: -
Identifier Source: org_study_id